Related Experiment Video
Updated: Mar 9, 2026

07:20
A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
10.5K
Risk factors for mortality in patients with anti-NMDA receptor encephalitis
1Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Acta Neurologica Scandinavica
|December 29, 2016
Summary
Predictors of death in anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis include low Glasgow Coma Scale scores, numerous complications, and intensive care unit admission. Managing complications may improve patient outcomes in this severe autoimmune disorder.
Area of Science:
- Neurology
- Immunology
- Critical Care Medicine
Background:
- Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe autoimmune neurological disorder with significant mortality.
- Few studies have comprehensively investigated the predictors of death in anti-NMDAR encephalitis patients.
Purpose of the Study:
- To identify predictors of mortality in patients diagnosed with anti-NMDAR encephalitis.
- To explore the primary causes of death in this patient cohort.
Main Methods:
- A cohort study involving patients with anti-NMDAR encephalitis from June 2011 to October 2015.
- Long-term follow-up to evaluate patient outcomes.
- Cox regression analysis to determine associations between predictors and mortality.
Main Results:
- The study included 96 patients, with 11 deaths (11.46% mortality) over a median follow-up of 24.5 months.
- Predictors of increased mortality included Glasgow Coma Scale (GCS) score ≤8 at admission, a higher number of complications, and intensive care unit (ICU) admission.
- Main causes of death were severe pneumonia, multiple organ dysfunction syndrome, and refractory status epilepticus.
Conclusions:
- Low GCS score on admission, increased number of complications, and ICU admission are significant predictors of mortality in anti-NMDAR encephalitis.
- Effective management of complications is crucial for improving the prognosis of patients with anti-NMDAR encephalitis.
More Related Videos
Related Concept Videos
Drug Toxicity: Risk factors
68
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
68
Myocarditis III: Medical Management
286
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
286
Myocarditis II: Clinical Features and Diagnostic Tests
395
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
395

